Acorai company

Overview

Acorai is developing a non-invasive intracardiac pressure monitoring device for heart failure management, built on its patented SAVE Sensor System and machine-learning models; the device received FDA Breakthrough Device designation in 2023. Founded in 2019 by Filip Peters, Jakob Gelberg and Kasper Bourdette, and a Creative Destruction Lab portfolio company.

Key Facts

Sector

MedTech

Focus Areas